Time in therapeutic range: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:


==Factors Affecting Time in Therapeutic Range==
==Factors Affecting Time in Therapeutic Range==
Cross Trial Comparisons of TTR are hampered by variations in:
• CHADS Score: Higher the CHADS score, lower the TTR. Sicker patients may have reduced access to frequent testing.
• Age: Older patients may have reduced access to frequent testing
• CHF: Varying drug clearance and distribution (CHF: 63% in ROCKET,  32% RELY, 35% ARISTOTLE)
• Country: Highest in Scandanavia, lowest in developing countries
• What is the TTR in ROCKET AF in those countries who conducted RE-LY and vice versa (adjusting for the number of sites in each country)?
• Should trials only be conducted in countries with a high TTR or should sponsors conduct real world trials throughout the world?

Revision as of 12:41, 8 September 2011

WikiDoc Resources for Time in therapeutic range

Articles

Most recent articles on Time in therapeutic range

Most cited articles on Time in therapeutic range

Review articles on Time in therapeutic range

Articles on Time in therapeutic range in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Time in therapeutic range

Images of Time in therapeutic range

Photos of Time in therapeutic range

Podcasts & MP3s on Time in therapeutic range

Videos on Time in therapeutic range

Evidence Based Medicine

Cochrane Collaboration on Time in therapeutic range

Bandolier on Time in therapeutic range

TRIP on Time in therapeutic range

Clinical Trials

Ongoing Trials on Time in therapeutic range at Clinical Trials.gov

Trial results on Time in therapeutic range

Clinical Trials on Time in therapeutic range at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Time in therapeutic range

NICE Guidance on Time in therapeutic range

NHS PRODIGY Guidance

FDA on Time in therapeutic range

CDC on Time in therapeutic range

Books

Books on Time in therapeutic range

News

Time in therapeutic range in the news

Be alerted to news on Time in therapeutic range

News trends on Time in therapeutic range

Commentary

Blogs on Time in therapeutic range

Definitions

Definitions of Time in therapeutic range

Patient Resources / Community

Patient resources on Time in therapeutic range

Discussion groups on Time in therapeutic range

Patient Handouts on Time in therapeutic range

Directions to Hospitals Treating Time in therapeutic range

Risk calculators and risk factors for Time in therapeutic range

Healthcare Provider Resources

Symptoms of Time in therapeutic range

Causes & Risk Factors for Time in therapeutic range

Diagnostic studies for Time in therapeutic range

Treatment of Time in therapeutic range

Continuing Medical Education (CME)

CME Programs on Time in therapeutic range

International

Time in therapeutic range en Espanol

Time in therapeutic range en Francais

Business

Time in therapeutic range in the Marketplace

Patents on Time in therapeutic range

Experimental / Informatics

List of terms related to Time in therapeutic range

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: TTR

Overview

Factors Affecting Time in Therapeutic Range

Cross Trial Comparisons of TTR are hampered by variations in:

• CHADS Score: Higher the CHADS score, lower the TTR. Sicker patients may have reduced access to frequent testing.

• Age: Older patients may have reduced access to frequent testing

• CHF: Varying drug clearance and distribution (CHF: 63% in ROCKET, 32% RELY, 35% ARISTOTLE)

• Country: Highest in Scandanavia, lowest in developing countries

• What is the TTR in ROCKET AF in those countries who conducted RE-LY and vice versa (adjusting for the number of sites in each country)?

• Should trials only be conducted in countries with a high TTR or should sponsors conduct real world trials throughout the world?